Evidence supporting the use of: N-acetyl-cysteine (NAC)
For the health condition: Heavy Metal Poisoning

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

N-acetyl-cysteine (NAC) has some scientific basis for use in cases of heavy metal poisoning, particularly as an adjunct treatment. NAC is a precursor to glutathione, a major intracellular antioxidant that plays a crucial role in detoxification processes, including the binding and removal of heavy metals. Several preclinical (animal and in vitro) studies have demonstrated that NAC can chelate certain metals (like mercury, lead, and cadmium) and help reduce their toxic effects, primarily by replenishing glutathione stores and enhancing cellular antioxidant capacity. Limited clinical studies and case reports in humans suggest that NAC may aid in reducing oxidative stress and tissue damage associated with heavy metal toxicity, and may be used alongside conventional chelating agents to improve outcomes. However, NAC is not a primary chelator and is generally not considered a substitute for established chelation therapies such as EDTA, DMSA, or DMPS. Its primary role is supportive, aiming to limit oxidative damage during acute exposure.

Overall, while the mechanistic rationale is strong and preclinical evidence is promising, clinical evidence in humans is limited. Guidelines do not recommend NAC as a first-line agent for heavy metal poisoning, but it may be used as adjunct support in some cases. Therefore, the scientific evidence supporting its use is moderate but not definitive.

More about N-acetyl-cysteine (NAC)
More about Heavy Metal Poisoning